[CAS NO. 1303470-48-5]  KHK-IN-1hydrochloride

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1303470-48-5]

Catalog
HY-12841A
Brand
MCE
CAS
1303470-48-5

DESCRIPTION [1303470-48-5]

Overview

MDLMFCD29472233
Molecular Weight459.01
Molecular FormulaC21H27ClN8S
SMILES[H]Cl.CSC(C=CC=C1)=C1NC2=NC(N3CCNCC3)=NC4=C2N=CN=C4NCC5CC5

For research use only. We do not sell to patients.

Summary

KHK-IN-1 hydrochloride (compound 8) is a selective and cell membrane permeable ketohexokinase ( KHK ) inhibitor ( IC 50 =12 nM; F=34%). KHK-IN-1 hydrochloride inhibits the production of F1P in HepG2 cell lysates ( IC>sub>50 =400 nM). KHK-IN-1 hydrochloride has potential for the study of diabetes and obesity [1] .


IC50 & Target

IC50=12 nM (KHK) [1] .


In Vitro

KHK-IN-1 hydrochloride stable in human and rat liver microsome preparations (88 and 72% remaining at 10 min) and do not significantly inhibit cytochrome P450s from human liver microsomes (1A2, 2C19, 2D6, 2C9, and 3A4) [1] .
KHK-IN-1 hydrochloride (0-10 µM; incubate 30 min, then add to 15 mM fructose and incubate for another 3 h) inhibits production of F1P in HepG2 cell lysates with an IC 50 value of 400 nM [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: HepG2 cells
Concentration: 0-10 µM
Incubation Time: Incubate 30 min, then add to 15 mM fructose and incubate for another 3 h
Result: Exhibited inhibition of F1P production in HepG2 cell lysates (IC 50 =400 nM).

In Vivo

KHK-IN-1 hydrochloride (10 mg/kg; p.o.; single) shows oral bioavailability of 34% in rats [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague-Dawley rats (~250 g) [1] .
Dosage: 10 mg/kg
Administration: Oral gavage; single
Result: Exhibited reasonable oral bioavailability in rats (F=34%; oral t 1/2 =4 h), but had a high volume of distribution (Vd ss = 32 L/kg) and a high rate of clearance (CL=160 mL/min/kg).

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

-20°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 25 mg/mL ( 54.47 mM ; Need ultrasonic)

H 2 O : 14.29 mg/mL ( 31.13 mM ; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1786 mL 10.8930 mL 21.7860 mL
5 mM 0.4357 mL 2.1786 mL 4.3572 mL
10 mM 0.2179 mL 1.0893 mL 2.1786 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (4.53 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (4.53 mM); Clear solution

* All of the co-solvents are available by MCE.